Home
Resources
Follow portfolio news
...

Genesis MedTech seals partnership to bring AI to Singapore operating rooms

Published on
3/12/2025
Amended on
23/3/2026
0
minute(s)
Odyssey 2021
Genesis MedTech
Based in Singapore, Genesis MedTech has just signed a partnership agreement with the National University Health System (NUHS) to accelerate the use of artificial intelligence in Singaporean operating rooms. Featured in the Vintage Altaroc Odyssey , Genesis MedTech has unveiled this major collaboration, which aims to make surgery safer, more precise, and more accessible.
By
Antoine Orsoni
Antoine Orsoni
Genesis MedTech seals partnership to bring AI to Singapore operating rooms
This article has been automatically translated. Please excuse any inaccuracies or translation errors.
Dieser Artikel wurde automatisch übersetzt. Bitte entschuldigen Sie etwaige Ungenauigkeiten oder Übersetzungsfehler.
Questo articolo è stato tradotto automaticamente. Ci scusiamo per eventuali inesattezze o errori di traduzione.

Genesis MedTech designs and deploys medical technologies that make treatments accessible to as many people as possible, from operating rooms to cardiology departments. With an integrated model that combines research, manufacturing, and training, the company accelerates the adoption of innovative solutions by hospitals and advances the quality of care in South Asia. NUHS is one of Singapore's largest public healthcare groups, bringing together several hospitals, specialist centers, and medical schools. It brings together doctors, researchers, and students, trains healthcare professionals, and develops the treatments of tomorrow.

Genesis MedTech and NUHS are combining their expertise to develop, test, and deploy new AI solutions capable of supporting surgeons in increasingly complex procedures. These new technologies analyze images, movements, and vital signs in real time to help practitioners make the safest and most relevant decisions possible. In the operating room, this means smoother, less risky, and potentially shorter surgeries. At the hospital level, this translates into more personalized care, but also reduced costs thanks to better anticipation of complications.

This collaboration responds to a very clear trend in the sector. Hospitals around the world are facing growing needs: an aging population, an increase in chronic diseases, and increasingly complex procedures. AI appears to be a promising solution for supporting medical teams, reducing the risk of error, and streamlining the organization of care. In Asia, as elsewhere, studies are converging . The gradual integration of artificial intelligence into surgery could reduce post-operative complications and improve the precision of surgical procedures.

This partnership takes a very pragmatic approach. It starts with the specific needs on the ground to create tools that are truly useful in clinical settings. Teams from NUHS will be directly involved in order to steer technological development in the right direction, identify situations where AI can bring significant added value, and avoid designing innovations that do not meet an urgent need. The project also includes the creation of the Genesis-NUHS AI Innovation and Surgical Training Lab, a space dedicated to training and experimentation, where engineers and surgeons will work hand in hand.

Other episodes on this topic

Explore our content collections, which bring together different formats around a single subject/issue/theme.
No articles in this category yet.
No items found.
Rest of the world
Healthcare
Welcome to Altaroc
To provide you with a tailored experience, we invite you to complete your profile.
Your profile
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
Your investor profile
Financial intermediary or Professional investor
Financial advisors, wealth management advisors, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced Investor or Altaroc Investor
Private investors who have already invested in Altaroc who have a minimum investment capacity of €100,000.
Private investors who have already invested in Altaroc who have a minimum investment capacity of €250,000.
Inexperienced investor
Individual investors with an investment capacity of less than €100,000.
Individual investors with an investment capacity of less than €250,000.
Institutional investor
Pension funds, retirement funds, asset management firms, and single-family offices.
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.